Complete Filing Data
Genenta Science S.p.A. reported Stockholders Equity of $12.50 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Genenta Science S.p.A. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$8.9M | -$11.6M | -$8.5M | -$5.5M | -$5.6M | -$4.6M |
| Research And Development Expense | $4.8M | $6.5M | $5.3M | $3.4M | $4.7M | $3.7M |
| Other Nonoperating Income Expense | $529.7K | -$4.9K | $242.6K | $19.7K | $6.0K | $36.3K |
| Operating Income Loss | -$9.8M | -$11.7M | -$11.0M | -$5.7M | -$5.6M | -$4.6M |
| Operating Expenses | $9.8M | $11.7M | $11.0M | $5.7M | $5.6M | $4.6M |
| Nonoperating Income Expense | $851.8K | $87.5K | $2.6M | $157.9K | -$1.8K | $26.8K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$8.9M | -$11.6M | -$8.5M | -$5.5M | -$5.6M | -$4.6M |
| General And Administrative Expense | $5.0M | $5.3M | $5.7M | $2.3M | $901.8K | $921.5K |
| Comprehensive Income Net Of Tax | -$9.1M | -$11.4M | -$8.5M | -$5.5M | -$5.6M | -$4.6M |
| Other Comprehensive Income Loss Net Of Tax | $142.2K | $199.1K | ||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$142.2K | $199.1K | ||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent | -$23.4K | -$15.9K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $12.5M | $20.4M | $31.1M | $38.9M | $15.2M | $18.9M | $7.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $4.6M | $3.7M | $29.8M | $37.2M | $15.5M | $20.1M | $7.9M |
| Cash And Cash Equivalents At Carrying Value | $4.6M | $3.7M | $29.8M | $37.2M | $15.5M | ||
| Retained Earnings Accumulated Deficit | -$56.1M | -$47.1M | -$35.5M | -$27.0M | -$21.5M | ||
| Property Plant And Equipment Net | $42.9K | $83.0K | $111.6K | $23.1K | $19.0K | ||
| Prepaid Expense And Other Assets Current | $1.8M | $2.5M | $1.9M | $1.5M | $947.5K | ||
| Other Liabilities Current | $337.8K | $255.1K | $297.9K | $100.7K | $53.2K | ||
| Liabilities Noncurrent | $228.9K | $179.2K | $116.2K | $30.6K | $17.4K | ||
| Liabilities Current | $2.1M | $1.7M | $2.2M | $1.1M | $2.3M | ||
| Liabilities And Stockholders Equity | $14.8M | $22.3M | $33.4M | $40.0M | $17.5M | ||
| Assets Noncurrent | $351.0K | $1.1M | $1.7M | $1.3M | $967.9K | ||
| Assets Current | $14.5M | $21.3M | $31.7M | $38.8M | $16.5M | ||
| Assets | $14.8M | $22.3M | $33.4M | $40.0M | $17.5M | ||
| Common Stock Value | $68.5M | $67.3M | $66.6M | $65.9M | |||
| Other Liabilities Noncurrent | $1.2K | $14.6K | $27.2K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations | $890.3K | -$26.1M | -$7.4M | $21.8M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.4M | $21.8M | -$4.7M | $12.3M | |||
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | $227.8K | $164.7K | $89.0K | ||||
| Marketable Securities Current | $8.1M | $15.1M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $88.9K | $231.1K | |||||
| Other Non Current Assets Related Party | $3.4K | $3.4K | $3.4K | ||||
| Other Assets Noncurrent | $1.6M | $1.2M | $945.6K | ||||
| Accrued Liabilities Related Party | $489.2K | $132.1K | $1.4M | ||||
| Accrued Liabilities Current | $202.4K | $712.3K | $366.0K | ||||
| Accounts Payable Related Party | $152.0K | $25.0K | $10.0K | ||||
| Accounts Payable Current | $1.0M | $164.8K | $545.0K | ||||
| Change Of Marketable Debt Securities | -$118.8K | $215.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $847.3K | $739.9K | $722.7K | $497.1K | $460.2K | $749.5K |
| Net Cash Provided By Used In Operating Activities | -$6.2M | -$11.2M | -$7.4M | -$7.0M | -$6.0M | -$2.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$667.3K | $554.0K | $407.5K | $450.1K | $454.1K | -$151.1K |
| Increase Decrease In Other Noncurrent Assets | -$699.8K | -$596.9K | $427.9K | $295.6K | $200.3K | $588.7K |
| Increase Decrease In Other Current Liabilities | $82.7K | -$42.8K | $197.2K | $47.5K | $5.2K | $18.2K |
| Increase Decrease In Accrued Liabilities Related Party | $169.8K | $372.4K | $357.1K | -$1.2M | -$292.4K | $1.7M |
| Increase Decrease In Accrued Liabilities | $79.2K | -$49.3K | -$509.9K | $346.3K | $38.3K | $133.8K |
| Increase Decrease In Accounts Payable Related Party | $9.2K | $18.9K | $126.9K | $15.0K | -$282.7K | -$217.7K |
| Increase Decrease In Accounts Payable | $22.9K | -$747.1K | $877.2K | -$380.2K | $265.3K | $190.1K |
| Payments To Acquire Property Plant And Equipment | $4.5K | $13.8K | $27.1K | $9.0K | $20.9K | |
| Net Cash Provided By Used In Investing Activities | $6.9M | -$14.9M | -$27.1K | -$9.0K | -$20.9K | |
| Depreciation Depletion And Amortization | $44.5K | $42.5K | $6.1K | $4.9K | $1.9K | |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $739.9K | $722.7K | $497.1K | $460.2K | $749.5K | |
| Net Cash Provided By Used In Financing Activities | $270.9K | $531.00 | $28.7M | $1.4M | $14.8M | |
| Increase Decrease In Other Noncurrent Liabilities | -$13.4K | -$12.6K | $27.2K | |||
| Payments To Acquire Marketable Securities | $16.4M | $14.9M | ||||
| Stock Issued During Period Value Share Based Compensation | $847.3K | $739.9K | $722.7K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations | -$23.4K | -$6.3K | ||||
| Proceeds From Stock Options Exercised | $543.00 | |||||
| Proceeds From Sale And Maturity Of Marketable Securities | $23.3M | |||||
| Proceeds From Issuance Or Sale Of Equity | $270.9K | $531.00 | ||||
| Proceeds From Issuance Of Common Stock | $1.5M | $15.1M | ||||
| Proceeds From Issuance Initial Public Offering | $28.7M | |||||
| Payments Of Stock Issuance Costs | $68.1K | $318.5K | ||||
| Payments For Prepaid Offering Costs | $43.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Common Stock Shares Outstanding | 18.3M | 18.2M | 18.2M | 18.2M | 18.2M |
| Common Stock Shares Authorized | 59.7M | 59.7M | 59.7M | 59.7M | 59.7M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 18.2M | 18.2M | 15.1M | ||
| Earnings Per Share Basic | $-0.64 | $-0.47 | $-0.37 | ||
| Common Stock Shares Issued | 18.2M | 18.2M | 18.2M | 18.2M | |
| Weighted Average Number Of Diluted Shares Outstanding | 18.3M | 18.2M | 18.2M | 15.1M | |
| Earnings Per Share Diluted | $-0.49 | $-0.64 | $-0.47 | $-0.37 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash | $63.1K | $75.7K | $58.3K | $13.2K | $6.1K | $4.9K |
| Finance Income Expenses | $81.1K | $309.3K | $37.0K | -$11.7K | -$7.8K | -$9.6K |
| Foreign Currency Transaction Gain Loss Unrealized | $241.0K | -$216.9K | $2.3M | |||
| Stock Issued During Period Value Stock Options Exercised | $715.00 | |||||
| Retirement Benefit Obligation | $164.7K | $89.0K | $30.6K | $17.4K | ||
| Foreign Currency Transaction Gain Loss Before Tax | -$32.0K | |||||
| Stock Repurchased During Period Value | $172.00 | |||||
| Stock Issued During Period Value New Issues | $270.9K | $531.00 |
Most recent annual filing with the SEC: March 28, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.